Oxford University breakthrough on global COVID-19 vaccine
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019...
Brazil cases shed more light on COVID-19 reinfection risk
Researchers believe reinfection with SARS-CoV-2 may be more common than previously thought, after an analysis of people contracting COVID-19 twice.
Working with local biotech, University of Toronto to test drug that may prevent fatal...
The University of Toronto has partnered with Markham, Ont.-based Edesa Biotech on laboratory studies of a drug that physicians are already using at Canadian hospitals in a clinical...
UM survey shows over 60 per cent of Macao residents intent to receive COVID-19...
A research team from the University of Macau (UM) Institute of Chinese Medical Sciences (ICMS) recently conducted a survey on the intention of Macao residents to receive COVID-19 vaccine and its influencing factors in Macao.
New Zealand government takes a calculated risk to relax Auckland’s lockdown while new cases...
In an article on The Conversation UC Professor Michael Plank and Professor Shaun Hendy from the University of Auckland assess the risks that come with moving Auckland to Alert Level 3...
The paradox of Australia’s response to COVID-19
A new report has found that the agile stability embedded in Australia’s health care state was ultimately responsible for the nation’s high vaccination rates.
UOW to conduct study on the pandemic experience of essential workers
Researchers from the University of Wollongong (UOW) Faculty of the Arts, Social Sciences and Humanities are seeking people who worked in supermarkets and quarantine hotels during the COVID-19 pandemic...
Antipsychotic drug use increased in Canadian long-term care homes in first year of pandemic
While most aspects of care quality in long-term care homes did not differ in the first year of the pandemic from pre-pandemic levels, a new study shows that the use of antipsychotic drugs increased in all provinces.
QUT Advance Queensland COVID-19 Industry Research Fellowships
Seven QUT researchers have been awarded Advance Queensland Industry Research Fellowships in a round of research funding focused on COVID-19.
Coronavirus antibodies last at least three months after infection, University of Toronto study finds
Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a study published in Science Immunology.
- Advertisement -
